|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2170956 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08759230.9 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-22 |
| (46) | Date of publication of the claims translation | 2015-05-25 |
| (86) | Number | PCT/EP2008/004773 |
| Date | 2008-06-13 |
| (87) | Number | WO 2008/151819 |
| Date | 2008-12-18 |
| (30) | Number | Date | Country code |
| 944359 P | 2007-06-15 | US |
| (72) |
KELM, Daniela, DE
ALTEVOGT, Peter, DE
MOLDENHAUER, Gerhard, DE
BREITLING, Frank, DE
KRÜGER, Achim, DE
BÄRREITER, Silke, DE
LÜTTGAU, Sandra, DE
MÖBIUS, Ulrich, DE
LI, Yi, GB
SEBENS, Susanne, DE
SCHÄFER, Heiner, DE
|
| (73) |
Medigene AG,
Lochhamer Strasse 11, 82152 Planegg/Martinsried,
DE
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Im Neuenheimer Feld 280, 69120 Heidelberg, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Navikų gydymas, naudojant specifinį anti-L1 antikūną |
| TREATMENT OF TUMORS USING SPECIFIC ANTI-L1 ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2017-06-30 | 10 | 346.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-13 |